InvestorsHub Logo
Followers 14
Posts 2928
Boards Moderated 0
Alias Born 09/27/2010

Re: FORZANANO post# 108844

Thursday, 03/12/2015 3:20:22 AM

Thursday, March 12, 2015 3:20:22 AM

Post# of 146240
And that what's matter:

This study was developed in collaboration with BASi and conducted by BASi in a cGLP-like fashion in order to understand the safety parameters of FluCide intravenous dosing.

No direct adverse clinical effects were found upon administration of the FluCide candidate intravenously at doses of up to 300mg/kg/day for 14 days (a total of 4,200mg/kg) in rats.








GREAT PEOPLE TALK ABOUT IDEAS
AVERAGE PEOPLE TALK ABOUT THINGS
SMALL PEOPLE TALK ABOUT OTHER PEOPLE

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News